English: A female mosquito of the Culicidae family (Culiseta longiareolata). Size: about 10mm length Location: Lisbon region, Portugal Türkçe: Culiseta longiareolata türü di?i bir sivrisinek. (Photo credit: Wikipedia)
Vectored immunoprophylaxis (VIP) injection triggers creation of antibodies that prevent malaria in 70 percent of mice
A study led by Johns Hopkins Bloomberg School of Public Health researchers found that injecting a vaccine-like compound into mice was effective in protecting them from malaria. The findings suggest a potential new path toward the elusive goal of malaria immunization.
Mice injected with a virus genetically altered to help the rodents create an antibody designed to fight the malaria parasite produced high levels of the anti-malaria antibody. The approach, known as Vector immunoprophylaxis, or VIP, has shown promise in HIV studies. It had never before been tested with malaria, for which no licensed vaccine exists.
A report on the research appears online Aug. 11 in the Proceedings of the National Academy of Sciences (PNAS).
Malaria is one of the world’s deadliest infectious diseases, killing as many as 1 million people per year, the majority of them children in Africa. Malaria patients get the disease from infected mosquitoes. Of the four types of malaria that affect humans, the parasite Plasmodium falciparum is the most lethal, responsible for the majority of malaria cases. Antimalarial treatments and mosquito habitat modification have contributed to a decline in malaria mortality. But the number of cases remains high, and stemming them is a top global health priority.
In their study, researchers used a virus containing genes that were encoded to produce an antibody targeted to inhibit P. falciparum infection. Up to 70 percent of the mice injected with the VIP were protected from malaria-infected mosquito bites. In a subset of mice that produced higher levels of serum antibodies, the protection was 100 percent. The mice were tested a year after receiving a single injection of the virus and were shown to still produce high levels of the protective antibody.
The Latest on: Malaria vaccine
[google_news title=”” keyword=”Malaria vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Malaria vaccine
- Dr. Heller: Vaccines save lives. Please don't ignore your doctors.on February 1, 2023 at 2:11 am
I lost two friends to one of the strains of Covid 19. They both had refused the Covid vaccine, preferring to achieve “natural immunity”. Instead, they achieved “natural selection” and ...
- Fauci Q&A: On Masking, Vaccines, and What Keeps Him Up at Nighton January 30, 2023 at 8:42 am
The adviser to seven presidents reflects on his career, the highs and lows, and offers advice for staying safe 3 years into the COVID-19 pandemic.
- Repeated Malaria Expands Innate Immune Cell-Type in Ugandan Childrenon January 30, 2023 at 4:00 am
Malaria-induced innate immune modulation of an atypical cellular population plays a significant role in driving and maintaining immunity against malaria.
- Finally! A safe and effective vaccine against malariaon January 25, 2023 at 8:56 pm
A depiction of the life cycle of the malaria parasite showing the various stages relevant to vaccine design. (1) The mosquito vector, used in experimental protocols to immunise people with irradiated ...
- History, as WHO Approves World’s First Malaria Vaccineon January 20, 2023 at 4:00 pm
The World Health Organisation (WHO) yesterday endorsed the first ever vaccine to prevent malaria, debuting a tool that could save the lives of tens of thousands of children in Africa each year.
- In Vitro Malaria Sporozoite Production May Lead to Cheaper Vaccineson January 20, 2023 at 2:08 pm
“It will completely revolutionize the production [of vaccines].” Sporozoites, which are the sporelike infective form of the protozoan (hence the name), do not cause malaria themselves; once injected ...
- 3-Dose Malaria Vaccine Shows Promise in African Trialon January 6, 2023 at 4:55 am
FRIDAY, Jan. 6, 2023 (HealthDay News) – New research has confirmed that a three-dose malaria vaccine is both safe and effective in West African adults, including those previously exposed to malaria.
- Three-Dose Malaria Vaccine Shows Safety and Efficacyon January 6, 2023 at 1:41 am
Would you like to receive further email communication from Technology Networks? - Select - Yes No A three-dose regimen of a whole-parasite vaccine against malaria – called Plasmodium falciparum ...
- A three-dose malaria vaccine shows safety, efficacy in West African adultson January 4, 2023 at 10:02 am
A three-dose regimen of a whole-parasite vaccine against malaria—called Plasmodium falciparum sporozoite (PfSPZ) vaccine—demonstrated safety and efficacy when tested in adults living in ...
via Bing News
